Cosmetic Advisories

FDA Advisory No. 2018-274-A || Amendment to FDA Advisory No. 2018-274 “Public Health Warning Against the Use of Cosmetic Products Containing Banned Ingredient/s (Batch 10)” Dated 10 September 2018

The Food and Drug Administration (FDA) hereby advises the public that the cosmetic products listed in FDA Advisory No. 2018-274 “Public Health Warning Against the Use of Cosmetic Products Containing Banned Ingredient/s (Batch 10)” dated 10 September 2018 is amended to remove the products, SKINWHITE® POWERWHITENING® WHITENING LOTION INSTANT WHITE SPF 20 and SKINWHITE® POWERWHITENING® WHITENING LOTION KOJIC ACID SPF 20.

After coordination with the Market Authorization Holder (MAH), Splash Corporation, FDA has determined that the aforementioned cosmetic products are now compliant with the existing FDA rules, regulations and standards and has been issued the appropriate market authorization with the following details:

Brand Name: SKINWHITE®

  • Product Name: SKINWHITE® POWERWHITENING® WHITENING LOTION INSTANT WHITE SPF 20
  • Notification Number: NN-‎10000001521116
  • Validity: 17 March 2021
  • Market Authorization Holder: Splash Corporation
  • Country of Manufacture: Philippines

Brand Name: SKINWHITE®

  • Product Name: POWERWHITENING® WHITENING LOTION KOJIC ACID SPF 20
  • Notification Number: NN-‎1000001519799
  • Validity: 10 January 2021
  • Market Authorization Holder: Splash Corporation
  • Country of Manufacture: Philippines

The MAH is urged to strictly comply with FDA implemented laws, rules and regulations and to closely monitor the marketing of the subject products. Nothing in this Advisory shall preclude the FDA from pursuing further actions, as it may deem necessary, against the MAH, should the subject products, be confirmed to contain banned ingredients.

In view thereof, FDA Advisory No. 2018-274 is hereby updated accordingly. For more information and inquiries, please e-mail us at This email address is being protected from spambots. You need JavaScript enabled to view it.. To report any suspicious activity and/or product, kindly e-mail us via This email address is being protected from spambots. You need JavaScript enabled to view it., call us at the Center for Cosmetics Regulation and Research (CCRR) hotline (02) 857-1900 local 8113/8017, or utilize our online reporting facility, eReport, at www.fda.gov.ph/ereport.

Dissemination of the information to all concerned is requested.

 

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter